Russia approves 2nd coronavirus vaccine after early trials
Published
The peptide-based, two-shot vaccine, EpiVacCorona, was developed by the Vector Institute in Siberia
Full ArticlePublished
The peptide-based, two-shot vaccine, EpiVacCorona, was developed by the Vector Institute in Siberia
Full ArticleThere have been instances of infection among volunteers of Sputnik V trials, the world's first registered vaccine against Covid-19..
By Hannah Clapham*
With COVID-19 cases still rising globally, the race is on for a vaccine. Pressures are mounting to..